Centene Corporation

CNC Healthcare Healthcare Plans

Centene Corporation’s revenue for fiscal 2025 (year ended December 2025) was $194.8 billion, up 19.4% from fiscal 2024. In the quarter to June 2026, revenue grew 9.92%, EPS grew 533.3%, free cash flow grew 116.6% and total debt fell 8.37%, each against the same quarter a year earlier. Member of the S&P 500; revenue growth for ten consecutive years.

68.86 1.84 +2.75%
Market cap
$33.1B
P/E
0.0×
Fwd P/E
24.8×
Dividend yield
—
F-score
5/9
Altman Z
2.64
Beneish M
−3.07
Dividend safety
n/a
Older periods Sep '25 Dec '25 Mar '26 Jun '26
ROE

+8 more TTM periods

(21.85%) (28.69%) (26.03%) (20.35%)
Piotroski F-Score
4 5 6 6
ROA
(6.43%) (8.38%) (7.66%) (6.02%)
ROIC
(18.39%) (27.84%) (32.27%) (30.17%)
Return on Tangible Assets
(94.58%) (117.31%) (91.61%) (63.31%)
Average Days of Receivables
45.38 33.93 35.79 32.51
Free Cash Flow per Share
6.83 8.76 14.45 18.13
Free Cash Flow
3,356.00 4,321.00 7,112.00 8,951.00
Capital Expenditures
(708.00) (767.00) (832.00) (798.00)
Other line items
Cash ROIC
5.80% 7.48% 11.54% 13.60%
Accounts Receivable Turnover
8.98 10.30 9.46 10.24
Accounts Payable Turnover
11.30 13.42 11.95 11.88
Inventory Turnover
0.00 0.00 0.00 0.00
Average Days of Payables
36.08 27.83 33.41 35.05
Days of Inventory on Hand
0.00 0.00 0.00 0.00
Tax Rate
0.09 (0.01) 0.01 0.10
Research and Development Expense of Revenue
0.00% 0.00% 0.00% 0.00%
Selling, General and Administrative Expense of Revenue
6.87% 6.63% 6.54% 6.41%
Share Based Compensation of Revenue
0.10% 0.10% 0.11% 0.12%
Interest Coverage
(8.36) (11.24) (10.86) (8.61)
Operating CF/Net income
(0.77) (0.76) (1.23) (1.91)
Depreciation/Fixed assets
0.58 0.63 0.60 0.59
Capex/Depreciation
(0.56) (0.60) (0.66) (0.64)
Revenue per Share
378.42 394.99 402.59 410.96
Operating CF per Share
8.27 10.32 16.14 19.74
Capex per Share
(1.44) (1.56) (1.69) (1.62)
Capex to Sales
0.00 0.00 0.00 0.00

Fold the line items

Columns are period end dates